Medical/Pharmaceuticals
Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer
HONG KONG, Aug. 10, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase II clinical study (AK146D1-202) evaluating AK146D1, the Company's internally developed TROP2/Nectin-4 bispecific antibody-drug conjugate (bsADC), i...
2026 Global Health Summit Opens in Hong Kong -- Global Healthcare Leaders Convene: Bringing Breakthroughs to Patients
HONG KONG, Aug. 10, 2026 /PRNewswire/ -- The 2026 Global Health Summit ("GHS 2026"), jointly hosted by New Frontier Group ("New Frontier") and the Hong Kong Investment Corporation Limited ("HKIC"), opened today at the Hong Kong Convention and Exhibition Centre for a two-day programme. Held under ...
Second PIC/S GMP Certification | Mabwell Passes Brazilian GMP Inspection for Its Denosumab Injections
SHANGHAI, Aug. 9, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announces that its wholly-owned subsidiary T-mab has successfully passed Brazilian Health Regulatory Agency's ("ANVISA") GMP on-site inspect...
RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias
The FDA IND clearance supports the initiation of RiboX's Phase 1 clinical trial evaluating targeted LNP-delivered circular RNA-based in vivo CAR-T therapy for autoimmune cytopenias. RXIM002 represents the world's first circular RNA-based in vivo CAR-T therapy achieving FDA IND clearance. RiboX e...
Alebund's AP301 NDA Accepted for Review by China's NMPA
SHANGHAI, Aug. 7, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that the New Drug Application (NDA) for AP301 capsules, a novel oral iron-based phosphate binder, for the treatmen...
Check out Hainan's Pioneering Medical Hub
Uncover the New Charms of Boao Lecheng Medical Tourism HAIKOU, China, Aug. 7, 2026 /PRNewswire/ -- A news report from PDDC: Coastal scenery soothes body and mind, while cutting‑edge medical services empower health‑and‑wellness tourism. Bolstered by the opening‑up dividends of Hainan Free Trade P...
Yochanra®, the World's First Innovative Drug to Overcome FGFR Inhibitor Resistance, Makes Its Global Debut in China
NANJING, China and GAITHERSBURG, Md., Aug. 7, 2026 /PRNewswire/ -- TransThera Sciences' Yochanra® is the first drug independently developed in China to address the longstanding global challenge of acquired resistance to FGFR inhibitor therapy in patients with cholangiocarcinoma. On 6 August 2026,...
CLASSYS Appoints Former Samsung Electronics and Vuno Executive Dr. Taek-Soo Kim as Chief Technology Officer, Accelerating Its Evolution into a Global Medical Aesthetics Technology Company
SEOUL, South Korea, Aug. 7, 2026 /PRNewswire/ -- CLASSYS (KOSDAQ: 214150), a global medical aesthetics platform company, announced the appointment of Dr. Taek-Soo Kim, a distinguished technology management expert, as its new Chief Technology Officer (CTO) and Head of Research and Development. ...
Ractigen Therapeutics Announces Completion of Enrollment and First Dosing in Phase II Clinical Trial of RAG-17 for SOD1-ALS
NANTONG, China, Aug. 6, 2026 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics, today announced the completion of patient enrollment and initial dosing across all cohorts in its Phase II clinical trial evaluating RAG-17, an ...
Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq
SHANGHAI, Aug. 6, 2026 /PRNewswire/ -- Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of $17.00 per sha...
Harbour BioMed Appoints Dr. Bob Zhang as President of Metabolic Disease Franchise to Accelerate Global Development of Innovative Therapies
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Aug. 6, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment ...
Chugai Pharma Taiwan (CPT) Secures Dual Recognition at the Asia Responsible Enterprise Awards (AREA) for Health Promotion and Green Leadership Initiatives
SINGAPORE, Aug. 6, 2026 /PRNewswire/ -- Chugai Pharma Taiwan (CPT) was recognized at the Asia Responsible Enterprise Awards (AREA) 2026organised by Enterprise Asia under the Health Promotion and Green Leadership categories for its integrated ESG approach that advances human health, employee well-...
Fosun International Wins Three Awards from Global Banking & Finance Review, Gaining International Recognition for its ESG Performance, Corporate Social Responsibility, and Brand Strength
HONG KONG, Aug. 6, 2026 /PRNewswire/ -- Recently, Global Banking and Finance Review, a leading British financial magazine, announced its 2026 award winners. Fosun International Limited (HKEX stock code: 00656) received three awards in recognition of its outstanding contributions to sustainable de...
From Patient to Storyteller: Dale Returns to Shanghai After CAR-T Recovery, Sharing a Journey of Hope
SHANGHAI, Aug. 5, 2026 /PRNewswire/ -- After overcoming stage 4B lymphoma through CAR-T therapy, New Zealand patient Dale has returned to Shanghai—not as a patient seeking treatment, but as a survivor sharing his story. Recently, Dale came back to the city where he received life-changing care, to...
Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China
SAN FRANCISCO and SUZHOU, China, Aug. 5, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...
Telix to Host R&D Day in New York City on September 22, 2026
MELBOURNE, Australia and INDIANAPOLIS, Aug. 6, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that it will host a Research and Development (R&D) Day on Tuesday, September 22, 2026, from 8:30 a.m. to 12:30 p.m. EDT in New York City. Institutional...
NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 5, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins...
Nearly 3 in 10 Veterinarians at Japan's Larger Companion-Animal Hospitals Say Their Current Pace Is Unsustainable, Zpeer Survey Finds
TOKYO, August 5, 2026 /PRNewswire/ -- Zpeer Inc., operator of Vetpeer — Japan's largest online community for veterinary professionals, reaching approximately 80% of the country's small-animal veterinarians —today released the results of a survey of 314 companion-animal veterinarians on their work...
KPJ Healthcare and SingHealth Mark Strategic Partnership to Strengthen Future Healthcare Capabilities
JOHOR BAHRU, Malaysia, Aug. 5, 2026 /PRNewswire/ -- KPJ Healthcare Berhad ("KPJ Healthcare") marked the commencement of a strategic partnership with SingHealth, Singapore's largest and leading healthcare cluster, through the signing of a Memorandum of Understanding ("MoU"), establishing a long-te...
KPJ Healthcare and SingHealth Mark Strategic Partnership to Strengthen Future Healthcare Capabilities
JOHOR BAHRU, Malaysia, Aug. 5, 2026 /PRNewswire/ -- KPJ Healthcare Berhad ("KPJ Healthcare") marked the commencement of a strategic partnership with SingHealth, Singapore's largest and leading healthcare cluster, through the signing of a Memorandum of Understanding ("MoU"), establishing a long-te...
Week's Top Stories
Most Reposted
BoomerangFX Launches ChatGPT AI Search Advertising for Aesthetic, Wellness and Private-Pay Healthcare Practices, Powered by AUVIA™ AI Clinic Co-Pilot
[Picked up by 1315 media titles]
2026-11-17 23:03Manulife announces Subordinated Debenture issue
[Picked up by 1205 media titles]
2026-11-17 06:45vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1188 media titles]
2026-11-13 22:11The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1176 media titles]
2026-11-14 13:23Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1172 media titles]
2026-11-12 23:00